Ayana Bio produces and discovers plant bioactives for health and sustainability purposes. The company finds, creates, and scales complex molecules from plants that influence human health.

Ayana Bio

Ayana Bio leverages cellular technology to produce bioactive ingredients that support health and wellness. Ayana Bio collaborates with global industry leaders in food and beverages, dietary supplements, sports nutrition, animal care, and cosmetics to bring standardized plant and fungal bioactives to market. We provide consumers with confidence in quality and reliability. Ayana Bio has partnered with Ginkgo Bioworks, a synthetic biology platform company that is redesigning the living world to solve some of the globe’s growing challenges in health, energy, food, material, and more. Ayana Bio is backed by Viking Global Investors and Cascade Investment to democratize nature’s bioactives in a way that is standardized, safe, and sustainably sourced.

The declining nutritional content of many crops is an issue that Ayana Bio’s plant cell cultivation exists to solve.
#foodtech #biotechnology #plantcell

We're thrilled to share that Frank Jaksch, CEO of Ayana Bio, has contributed his expert thoughts on the effects of ingredient supply chains to Food Industry Executive. In his guest article, Frank highlights how CPG manufacturers can navigate the challenges of today's complex supply chains by exploring innovative solutions like plant cell cultivation.
#Sustainability #FoodIndustry #Biotechnology #Bioactives #CPG

Supply chain challenges in sourcing botanical ingredients are a reality. But there are innovative alternatives like precision fermentation and plant cell cultivation. Explore this infographic to discover the best solution for your needs.
#botanicals #fermentation #biotechnology #plantcellcultivation

Jill Zullo, PhD has joined the Board of Directors at Ayana Bio, and her expertise will drive innovation in plant cell technology, accelerating our mission to revolutionize bioactive sourcing. Thank you Phoebe Fraser for covering this news for The Cell Base. 
#Biotech #PlantCellTechnology #Leadership

What’s your top health priority this summer? Let us know by voting in our poll, and share your thoughts in the comments! 
#HealthPoll #Wellness #LinkedInPoll

We are pleased to announce the addition of Jill Zullo, PhD to the Ayana Bio Board of Directors. Dr. Zullo’s extensive experience in scaling new technology will accelerate Ayana Bio’s path to success as a leader in plant cell culture.

https://lnkd.in/gdP8RASx
#biotecnology #plantcellculture #AyanaBioLife

Metric
Company Name	Ayana Bio
Symbol
MSH ID	COM:AYANABIO
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage
Employee Count	28
Website	ayanabio.com
LinkedIn	ayana-bio
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:AYANABIO

Ayana Bio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue